All In Biotech

Drug Trial Radar · NCT02566928

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

Last checked: Nov 19, 2026Latest source record: Jul 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 278 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

278

Planned (sponsor's estimate)

Start

Oct 2015

Primary completion

Nov 2018

Study completion Dec 31, 2018

Sponsor

Lead sponsor
Clinical Directors NetworkResearch network
Sponsor type
Research network
Collaborators
Rockefeller University; Patient-Centered Outcomes Research Institute
First posted
Oct 2, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 7 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The overall goal of the project is to develop and evaluate a home-based intervention to prevent re-infection and transmission of Community-Acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) in patients presenting to primary care with skin or soft tissue infections (SSTIs). Centers for Disease Control (CDC) CA-MRSA guidelines include incision and drainage, antibiotic sensitivity testing and antibiogram-directed prescribing. Re-infections are common, ranging from 16% to 43%, and present significant challenges to clinicians, patients and their families. Several decolonization and decontamination interventions have been shown to reduce Hospital-Acquired MRSA (HA-MRSA) re-infection and transmission in intensive care units. Few studies examine the feasibility and effectiveness of these infection prevention interventions into primary care settings, and none employ Community Health Workers (CHWs) or "promotoras" to provide home visits for education and interventions about decolonization and decontamination. This comparative effectiveness research/patient centered outcomes research builds upon a highly stakeholder-engaged community-academic research and learning collaborative, including practicing clinicians, patients, clinical and laboratory researchers, and barbers/beauticians. Clinical Directors Network (CDN), an established, NIH-recognized best practice Federally Qualified Health Center (FQHC) Practice-based Research Network (PBRN), and The Rockefeller University propose to address this question through the completion of four aims: (1) To evaluate the comparative effectiveness of a CHW/Promotora-delivered home intervention (Experimental Group) as compared to Usual Care (Control Group) on the primary patient-centered and clinical outcome (SSTI recurrence rates) and secondary patient-centered and clinical outcomes (pain, depression, quality of life, care satisfaction) using a two-arm randomized controlled trial (RCT). (2) To understand the patient-level factors (CA-MRSA infection prevention knowledge, self-efficacy, decision-making autonomy, prevention behaviors/adherence) and environmental-level factors (household surface contamination, household member colonization, transmission to household members) that are associated with differences in SSTI recurrence rates. (3) To understand interactions of the intervention with bacterial genotypic and phenotypic variables on decontamination, decolonization, SSTI recurrence, and household transmission. (4) To explore the evolution of stakeholder engagement and interactions among patients and other community stakeholders with practicing community-based clinicians and academic laboratory and clinical investigators over the duration of the study period.

Conditions

  • Methicillin-Resistant Staphylococcus Aureus
  • Recurrence
  • Staphylococcal Skin Infections
  • Antibiotic Resistance

Interventions

  • 2% mupirocin ointmentDrug

    Index patients and consenting household members will complete a decolonization regimen consisting of twice-daily application of mupirocin ointment to the anterior nares with a sterile cotton applicator for five days.

  • Chlorhexidine washOther

    Index patients and consenting household members will daily daily for five days with chlorhexidine wash.

  • Hygiene protocolBehavioral

    Index patients and consenting household members will be given educational materials and instructed to in the use of hand-washing, surface disinfection, and laundering.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SSTI Recurrence RateTime frame: 3 months
  2. SSTI Recurrence RateTime frame: 6 months
  3. SSTI Recurrence RateTime frame: 12 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • NYU Lutheran Family Health Centers

    Brooklyn, New York · Recruiting

  • NYU Lutheran Medical Center Emergency Department

    Brooklyn, New York · Recruiting

  • Coney Island Hospital

    Brooklyn, New York · Recruiting

  • Community Healthcare Network

    New York, New York · Recruiting

  • Metropolitan Hospital Center

    New York, New York · Recruiting

  • Urban Health Plan

    The Bronx, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.